177 related articles for article (PubMed ID: 15577433)
1. A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
Eng C; Ramanathan RK; Wong MK; Remick SC; Dai L; Wade-Oliver KT; Mani S; Kindler HL
Am J Clin Oncol; 2004 Dec; 27(6):565-9. PubMed ID: 15577433
[TBL] [Abstract][Full Text] [Related]
2. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
Meyerhardt JA; Zhu AX; Stuart K; Ryan DP; Blaszkowsky L; Lehman N; Earle CC; Kulke MH; Bhargava P; Fuchs CS
Dig Dis Sci; 2008 Feb; 53(2):564-70. PubMed ID: 17597402
[TBL] [Abstract][Full Text] [Related]
3. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas.
Kuhn R; Hribaschek A; Eichelmann K; Rudolph S; Fahlke J; Ridwelski K
Invest New Drugs; 2002 Aug; 20(3):351-6. PubMed ID: 12201499
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.
von Delius S; Lersch C; Schulte-Frohlinde E; Mayr M; Schmid RM; Eckel F
BMC Cancer; 2005 Jun; 5():61. PubMed ID: 15949047
[TBL] [Abstract][Full Text] [Related]
5. [Gemcitabine in the treatment of 4 patients with cholangiocarcinoma].
Gallardo J; Cabrera E; Rubio B; González C; Cortés C
Rev Med Chil; 2001 Aug; 129(8):911-6. PubMed ID: 11680965
[TBL] [Abstract][Full Text] [Related]
6. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
Iqbal S; Rankin C; Lenz HJ; Gold PJ; Ahmad SA; El-Khoueiry AB; Messino MJ; Holcombe RF; Blanke CD
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1595-602. PubMed ID: 21556747
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.
Iyer RV; Gibbs J; Kuvshinoff B; Fakih M; Kepner J; Soehnlein N; Lawrence D; Javle MM
Ann Surg Oncol; 2007 Nov; 14(11):3202-9. PubMed ID: 17705089
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Malka D; Cervera P; Foulon S; Trarbach T; de la Fouchardière C; Boucher E; Fartoux L; Faivre S; Blanc JF; Viret F; Assenat E; Seufferlein T; Herrmann T; Grenier J; Hammel P; Dollinger M; André T; Hahn P; Heinemann V; Rousseau V; Ducreux M; Pignon JP; Wendum D; Rosmorduc O; Greten TF;
Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116
[TBL] [Abstract][Full Text] [Related]
10. Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study.
Park JS; Oh SY; Kim SH; Kwon HC; Kim JS; Jin-Kim H; Kim YH
Jpn J Clin Oncol; 2005 Feb; 35(2):68-73. PubMed ID: 15709089
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Al-Khatib H; Mahoney MR; Burgart L; Cera PJ; Flynn PJ; Finch TR; Levitt R; Windschitl HE; Knost JA; Tschetter LK
Cancer; 2005 Jan; 103(1):111-8. PubMed ID: 15558814
[TBL] [Abstract][Full Text] [Related]
12. Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer.
Tsavaris N; Kosmas C; Gouveris P; Gennatas K; Polyzos A; Mouratidou D; Tsipras H; Margaris H; Papastratis G; Tzima E; Papadoniou N; Karatzas G; Papalambros E
Invest New Drugs; 2004 Apr; 22(2):193-8. PubMed ID: 14739669
[TBL] [Abstract][Full Text] [Related]
13. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma.
Charoentum C; Thongprasert S; Chewaskulyong B; Munprakan S
World J Gastroenterol; 2007 May; 13(20):2852-4. PubMed ID: 17569122
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater.
Sohn BS; Yuh YJ; Kim KH; Jeon TJ; Kim NS; Kim SR
Tumori; 2013; 99(2):139-44. PubMed ID: 23748804
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
17. Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies.
Gray HJ; Bell-McGuinn K; Fleming GF; Cristea M; Xiong H; Sullivan D; Luo Y; McKee MD; Munasinghe W; Martin LP
Gynecol Oncol; 2018 Mar; 148(3):507-514. PubMed ID: 29352572
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study.
Yamashita Y; Taketomi A; Fukuzawa K; Yoshizumi T; Uchiyama H; Simada M; Shirabe K; Wakasugi K; Maehara Y
Anticancer Res; 2006; 26(1B):771-5. PubMed ID: 16739352
[TBL] [Abstract][Full Text] [Related]
19. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.
Morine Y; Shimada M; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Imura S
Anticancer Res; 2017 Nov; 37(11):6421-6428. PubMed ID: 29061828
[TBL] [Abstract][Full Text] [Related]
20. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ
JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
